Clinical Trial Update: Meclizine for Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating meclizine for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Meclizine (meclizine)

Snippet

Sponsor: Tannaz Armaghnay | Conditions: Carcinoma, Hepatocellular | Phase 1 | Status: COMPLETED